<DOC>
	<DOCNO>NCT01256255</DOCNO>
	<brief_summary>The investigator purpose prospectively characterize influenza infection 3 year period transplant patient use registry system . The investigator plan generate robust data clinical feature upper low respiratory disease , antiviral therapy effect disease outcome , well quantitative virologic data shed antiviral resistance . The investigator also study long term sequela influenza infection look development rejection .</brief_summary>
	<brief_title>Influenza Virus - A Multicenter Registry</brief_title>
	<detailed_description>This study prospective , multi-center study conduct investigator site comprise Influenza Transplant collaborative study group . This include 30 center across North America Europe . The co-ordinating center University Alberta . We aim enrol 300 patient registry 3 year period . The following information gather : 1 . Clinical Information - Baseline demographic information transplant ( include immunosuppression , graft function ) - Comorbidities diabetes , obesity , chronic lung disease - Symptoms infection , radiologic feature infection - Antiviral use - History vaccination - Outcomes hospitalization , ICU admission , mechanical ventilation , death - Long term outcome : allograft function , chronic respiratory disease - Laboratory parameter include lymphocyte count , immunoglobulin level , renal function - Adverse event - serious adverse event occur study ( till day 180 ) report . These include : ) hospitalization ; b ) congenital deformity ; c ) death ; ) disability ; e ) adverse event investigator considers serious . Pregnancy follow-up period also report . 2 . Virology - Method diagnosis ( DFA , viral culture , PCR ) - Subtype influenza virus ( ie HxNx ) - Viral Shedding serial NP swab day 0 ( diagnosis ) , 3 , 6 , 11 , 18 , 28 ( weekly thereafter shed persists ) - Quantitative PCR NP swab ( centrally University Alberta ) - Antiviral resistance test first last positive swab 3 . Immunology - Serum collection disease onset 4-6 week afterwards - Serology circulate influenza virus - Production HLA alloantibodies Significance : Despite recognize importance influenza transplant patient , actually limited prospective data . This registry represent large prospective data collection influenza transplant patient provide invaluable data clinical presentation , antiviral efficacy parameter related influenza .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>Solid organ transplant recipient least one immunosuppressive medication Hematopoietic stem cell transplant recipient allogeneic autologous Pediatric Adult Diagnosis influenza infection standard laboratory technique able comply protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>transplant</keyword>
	<keyword>influenza infection</keyword>
</DOC>